Your Health, We Care
Cholangiocarcinoma is a malignant tumor of the digestive tract, and patients with advanced stage are prone to obstructive jaundice, so special attention should be paid to dietary modification during medication.
Patients with cholangiocarcinoma are prone to obstructive jaundice, which is manifested as yellow staining of the skin, sclera, and mucous membranes.
Patients with advanced cholangiocarcinoma may present with cholestasis and need to be alert to the risk of bacterial infection. The appearance of these symptoms should be closely monitored during medication.
Patients with advanced cholangiocarcinoma need regular reexaminations during the treatment period to confirm the changes in the disease.
It is recommended to recheck the liver ultrasound, liver CT, or magnetic resonance examination every half a month or so, so as to detect the changes in the condition in time and give corresponding treatment.
